Chimeric Therapeutics Ltd
ASX:CHM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chimeric Therapeutics Ltd
ASX:CHM
|
AU |
|
Stericycle Inc
NASDAQ:SRCL
|
US |
|
Prairiesky Royalty Ltd
TSX:PSK
|
CA |
|
Enapter AG
F:H2O
|
DE |
|
INOVIQ Ltd
ASX:IIQ
|
AU |
Shareholder Yield
Current shareholder yield for CHM is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CHM Price
Chimeric Therapeutics Ltd
| Average Annual Return | -51.35% |
| Standard Deviation of Annual Returns | 35.55% |
| Max Drawdown | -100% |
| Market Capitalization | 8.6m AUD |
| Shares Outstanding | 51 984 752 |
| Percentage of Shares Shorted |
N/A
|
CHM Return Decomposition
Main factors of price return
Stock Splits
CHM's latest stock split occurred on Apr 22, 2026
The company executed a 1-for-100 stock split, meaning that for every 100 shares held, investors received 1 new share.
Before the split, CHM traded at 0.002 per share. Afterward, the share price was about 0.17.
The adjusted shares began trading on Apr 22, 2026. This was the only stock split in CHM's history.
